Dr. Edwin Yau, MD, PHD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 75
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: State University of New York at Buffalo School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
NY license 289882
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Roswell PArk Cancer Institute (488 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 75
- Services billed
- 214
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 148 | 54 |
| Established patient office or other outpatient visit, 20-29 minutes | 44 | 32 |
| New patient office or other outpatient visit, 45-59 minutes | 24 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prochlorperazine Maleate Other prescribers in Buffalo, NY | 46 |
| Dexamethasone Other prescribers in Buffalo, NY | 44 |
| Tagrisso (osimertinib mesylate) | 25 |
| Folic Acid Other prescribers in Buffalo, NY | 17 |
| Gabapentin Other prescribers in Buffalo, NY | 12 |
| Prednisone Other prescribers in Buffalo, NY | 12 |
| Olanzapine Other prescribers in Buffalo, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $21.28 in total to this clinician.
| Sun Pharmaceutical Industries Inc. | $21.28 |
|---|
| Food and Beverage | $21.28 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,769 in research payments for these studies, mostly to the institutions running them.
- Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Mirati Therapeutics, Inc. · Active, not recruiting · NCT03785249
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.